1. Johnson JL, West DA, Haggstrom AN. Pyoderma gangrenosum associated with an aseptic splenic abscess in a patient with neurofibromatosis. Pediatr Dermatol. doi:
10.1111/pde.12129. Published online ahead of print 28 March 2013.
Article
2. Allen CP, Hull J, Wilkison N, Burge SM. Pediatric pyoderma gangrenosum with splenic and pulmonary involvement. Pediatr Dermatol. 2013; 30:497–499. PMID:
23627664.
Article
3. Tavarela Veloso F. Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther. 2004; 20(Suppl 4):50–53. PMID:
15352894.
4. Callen JP. Pyoderma gangrenosum. Lancet. 1998; 351:581–585. PMID:
9492798.
Article
5. von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997; 137:1000–1005. PMID:
9470924.
Article
6. Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003; 30:97–107. PMID:
12641787.
Article
7. Yoo YW, Jung SH, Lee YJ, et al. A case of pyoderma gangrenosum associated with ulcerative colitis. Intest Res. 2008; 6:80–84.
8. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013; 7:1–33. PMID:
23040453.
Article
9. Paramkusam G, Meduri V, Gangeshetty N. Pyoderma gangrenosum with oral involvement - case report and review of the literature. Int J Oral Sci. 2010; 2:111–116. PMID:
20737938.
Article
10. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005; 53:273–283. PMID:
16021123.
Article
11. Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006; 55:505–509. PMID:
16188920.
Article